ROLE OF THE CYP1A2 GENE POLYMORPHISM ON EARLY AGEING FROM OCCUPATIONAL EXPOSURE

ROLE OF THE CYP1A2 GENE POLYMORPHISM ON EARLY AGEING FROM OCCUPATIONAL EXPOSURE

The ageing process is influenced by many internal and external factors. The toxic substances in the environment can cause genomic damages to cells, which increase the risk of early ageing. Furthermore, the cytochrome P450 1A2 (CYP1A2) gene polymorphism is a susceptibility factor and may enhance the...

Full description

Bibliographic Details
Main Authors:	Eshkoor Sa., Ismail P., Rahman Sa., Moin S., Adon My.
Format:	Article
Language:	English
Published:	Sciendo 2013-12-01
Series:	Balkan Journal of Medical Genetics
Subjects:	ageing buccal cells cytochrome p450 (cyp) cytochrome p450 1a2 (cyp1a2) gene polymorphism micronuclei (mn) test occupational exposure
Online Access:	https://doi.org/10.2478/bjmg-2013-0031

Similar Items

CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population
by: Renata dos Santos Coura, et al.
Published: (2007-01-01)

The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population
by: Merve Arici, et al.
Published: (2017-02-01)

The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy
by: Danxin Wang, et al.
Published: (2012-10-01)

Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review
by: Kenza Mansoor, et al.
Published: (2023-02-01)

Relationship between MspI polymorphism of CYP1A1 gene and the risk of endometriosis in an Iranian population: A case-control study
by: Azam Babaki, et al.
Published: (2018-10-01)

Association of CYP1A1*2C Variant (Ile464Val Polymorphism) and Some Hematological Parameters with Acute Myeloid Leukemia (AML) and Chronic Myeloid Leukemia (CML) in Erbil-Iraq.
by: Sumaya Basit Abdullah ,Mustafa Saber Al-Attar
Published: (2023-06-01)

Genetic variations in the drug metabolizing enzyme, CYP2E1, among various ethnic populations of Pakistan
by: Sagheer Ahmed, et al.
Published: (2020-08-01)

Isolation and characterization of the full-length cDNA encoding a member of a novel cytochrome p450 family (CYP320A1) from the tropical freshwater snail, Biomphalaria glabrata, intermediate host for Schistosoma mansoni
by: Anne E Lockyer, et al.
Published: (2005-05-01)

Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility
by: Meng Li, et al.
Published: (2019-08-01)

Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
by: Sabina Semiz, et al.
Published: (2011-02-01)

Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
by: Ann K. Daly, et al.
Published: (2017-12-01)

Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
by: Florian Klomp, et al.
Published: (2020-12-01)

Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?
by: Mohammed G. Maslub, et al.
Published: (2023-09-01)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
by: Kata W. Pedersen, et al.
Published: (2021-10-01)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
by: Yuanxia Cui, et al.
Published: (2020-08-01)

Expression of CYP2A3 mRNA and its regulation by 3-methylcholanthrene, pyrazole, and ß-ionone in rat tissues
by: A.B. Robottom-Ferreira, et al.
Published: (2003-07-01)

Hydration and Structural Adaptations of the Human CYP1A1, CYP1A2, and CYP1B1 Active Sites by Molecular Dynamics Simulations
by: Zbigniew Dutkiewicz, et al.
Published: (2023-07-01)

Prevalence of CYP2C19 Genetic Polymorphism among Normal People and Patients with Hepatic Diseases
by: Z Hashemizadeh, et al.
Published: (2018-01-01)

A Computational Inter-Species Study on Safrole Phase I Metabolism-Dependent Bioactivation: A Mechanistic Insight into the Study of Possible Differences among Species
by: Lorenzo Pedroni, et al.
Published: (2023-01-01)

Cytochrome P450 genes expression in human prostate cancer
by: Oksana Maksymchuk, et al.
Published: (2024-03-01)

Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population
by: Asif Jan, et al.
Published: (2023-08-01)

Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy
by: Samyuktha Lakkireddy, et al.
Published: (2015-10-01)

VDR, SOD-2, and CYP24A1 Gene Expression in Different Genotypes of BsmI SNP of the Vitamin D Receptor Gene in Individuals with Hypovitaminosis
by: Vanessa Rosa Retamoso, et al.
Published: (2023-08-01)

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment
by: Silvado CE, et al.
Published: (2018-03-01)

Cytochrome P450c17alpha (CYP17) gene polymorphism is not associated with leiomyoma susceptibility
by: Hsieh Yao-Yuan, et al.
Published: (2002-01-01)

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
by: Christopher Blazy, et al.
Published: (2022-06-01)

CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population
by: Merve Arici, et al.
Published: (2017-03-01)

Cytochrome P450 2A6 whole-gene deletion ( CYP2A6*4 ) polymorphism reduces risk of lung cancer: A meta-analysis
by: Fadzrul H. Johani, et al.
Published: (2020-06-01)

Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies
by: Smarakan Sneha, et al.
Published: (2021-03-01)

A Promiscuous Bacterial P450: The Unparalleled Diversity of BM3 in Pharmaceutical Metabolism
by: Sian Thistlethwaite, et al.
Published: (2021-10-01)

Prediction of Monomeric and Dimeric Structures of CYP102A1 Using AlphaFold2 and AlphaFold Multimer and Assessment of Point Mutation Effect on the Efficiency of Intra- and Interprotein Electron Transfer
by: Yuri D. Ivanov, et al.
Published: (2022-02-01)

Eficácia terapêutica do Tacrolimo em pacientes pós-transplante hepático com polimorfismos genéticos do citocromo P450 3A5 (CYP3A5)
by: Lucas Soares Bezerra, et al.

Molecular Dynamics Simulations of a Cytochrome P450 from <i>Tepidiphilus thermophilus</i> (P450-TT) Reveal How Its Substrate-Binding Channel Opens
by: Abayomi S. Faponle, et al.
Published: (2021-06-01)

Sex and Age Influence on Association of <i>CYP450</i> Polymorphism with Midazolam Levels in Critically Ill Children
by: Carmen Flores-Pérez, et al.
Published: (2022-11-01)

CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort
by: Hristo Y. Ivanov, et al.
Published: (2022-07-01)

Clinical Outcomes of Occupational Exposure to N,N-Dimethylformamide: Perspectives from Experimental Toxicology
by: Tae Hyun Kim, et al.
Published: (2011-06-01)

Preferential expression of cytochrome CYP CYP2R1 but not CYP1B1 in human cord blood hematopoietic stem and progenitor cells
by: Shuoqi Xu, et al.
Published: (2014-12-01)

Multiple CH/π Interactions Maintain the Binding of Aflatoxin B1 in the Active Cavity of Human Cytochrome P450 1A2
by: Jun Wu, et al.
Published: (2019-03-01)

Effects of CYP2C19 variants on the metabolism of tapentadol in vitro
by: Ren-ai Xu, et al.
Published: (2022-05-01)

CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer Polimorfismos dos alelos m1 e m2 do gene CYP1A1: Susceptibilidade genética para o cancro do pulmão
by: Paula Mota, et al.
Published: (2010-01-01)